{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:00:18Z","timestamp":1767924018399,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant peripheral nerve sheath tumors (MPNST) are aggressive cancers that occur spontaneously (sporadic MPNST) or from benign plexiform neurofibromas in neurofibromatosis type 1 (NF1) patients. MPNSTs metastasize easily, are therapy resistant and are frequently fatal. The molecular changes underlying the malignant transformation in the NF1 setting are incompletely understood. Here we investigate the involvement of microRNAs in this process. MicroRNA expression profiles were determined from a series of archival, paired samples of plexiform neurofibroma and MPNST. Ninety differentially expressed microRNAs were identified between the paired samples. Three downregulated microRNAs (let-7b-5p, miR-143-3p, miR-145-5p) and two upregulated microRNAs (miR135b-5p and miR-889-3p) in MPNST were selected for functional characterization. In general, their differential expression was validated in a relevant cell line panel but only partly in a series of unpaired, fresh frozen tumor samples. As part of the validation process we also analyzed microRNA expression profiles of sporadic MPNSTs observing that microRNA expression discriminates NF1-associated and sporadic MPNSTs. The role of microRNAs in cancer progression was examined in NF1-derived MPNST cell lines by transiently modulating microRNA levels. Our findings indicate that some microRNAs affect migratory and invasive capabilities and Wnt signaling activity but the effects are distinct in different cell lines. We conclude that miRNAs play essential regulatory roles in MPNST facilitating tumor progression.<\/jats:p>","DOI":"10.1038\/s41598-020-59789-4","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T11:03:30Z","timestamp":1582110210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors"],"prefix":"10.1038","volume":"10","author":[{"given":"Azadeh","family":"Amirnasr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia F.","family":"van Kuijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne L. M.","family":"Vriends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-9529","authenticated-orcid":false,"given":"Pim J.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-0996","authenticated-orcid":false,"given":"Martin E.","family":"van Royen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Taal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sleijfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-7236","authenticated-orcid":false,"given":"Erik A. C.","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"59789_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","volume":"115","author":"RE Ferner","year":"2013","unstructured":"Ferner, R. E. & Gutmann, D. H. Neurofibromatosis type 1 (NF1): diagnosis and management. Handb. Clin. Neurol. 115, 939\u2013955, https:\/\/doi.org\/10.1016\/B978-0-444-52902-2.00053-9 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"59789_CR2","doi-asserted-by":"crossref","unstructured":"Friedman, J. M. & Birch, P. H. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am. J. Med. Genet. 70, 138\u2013143, 10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-JMG7>3.0.CO;2-U (1997).","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U"},{"key":"59789_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann, D. H. et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278, 51\u201357, https:\/\/doi.org\/10.1001\/jama.1997.03550010065042 (1997).","journal-title":"JAMA"},{"key":"59789_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/glia.20776","volume":"56","author":"SL Carroll","year":"2008","unstructured":"Carroll, S. L. & Ratner, N. How does the Schwann cell lineage form tumors in NF1? Glia 56, 1590\u20131605, https:\/\/doi.org\/10.1002\/glia.20776 (2008).","journal-title":"Glia"},{"key":"59789_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.1068452","volume":"296","author":"Y Zhu","year":"2002","unstructured":"Zhu, Y., Ghosh, P., Charnay, P., Burns, D. K. & Parada, L. F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Sci. 296, 920\u2013922, https:\/\/doi.org\/10.1126\/science.1068452 (2002).","journal-title":"Sci."},{"key":"59789_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner, N. & Miller, S. J. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat. Rev. Cancer 15, 290\u2013301, https:\/\/doi.org\/10.1038\/nrc3911 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"59789_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans, D. G. et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J. Med. Genet. 39, 311\u2013314, https:\/\/doi.org\/10.1136\/jmg.39.5.311 (2002).","journal-title":"J. Med. Genet."},{"key":"59789_CR8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","volume":"19","author":"DG Evans","year":"2011","unstructured":"Evans, D. G. et al. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur. J. Hum. Genet. 19, 1187\u20131191, https:\/\/doi.org\/10.1038\/ejhg.2011.113 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"59789_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1086\/320121","volume":"68","author":"SA Rasmussen","year":"2001","unstructured":"Rasmussen, S. A., Yang, Q. & Friedman, J. M. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am. J. Hum. Genet. 68, 1110\u20131118, https:\/\/doi.org\/10.1086\/320121 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"59789_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","volume":"19","author":"M Farid","year":"2014","unstructured":"Farid, M. et al. Malignant peripheral nerve sheath tumors. Oncologist 19, 193\u2013201, https:\/\/doi.org\/10.1634\/theoncologist.2013-0328 (2014).","journal-title":"Oncologist"},{"key":"59789_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/annonc\/mdq338","volume":"22","author":"JR Kroep","year":"2011","unstructured":"Kroep, J. R. et al. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. Ann. Oncol. 22, 207\u2013214, https:\/\/doi.org\/10.1093\/annonc\/mdq338 (2011).","journal-title":"Ann. Oncol."},{"key":"59789_CR12","doi-asserted-by":"publisher","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, https:\/\/doi.org\/10.7554\/eLife.05005 (2015).","DOI":"10.7554\/eLife.05005"},{"key":"59789_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel, D. P. Metazoan MicroRNAs. Cell 173, 20\u201351, https:\/\/doi.org\/10.1016\/j.cell.2018.03.006 (2018).","journal-title":"Cell"},{"key":"59789_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857\u2013866, https:\/\/doi.org\/10.1038\/nrc1997 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"59789_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","volume":"9","author":"G Di Leva","year":"2014","unstructured":"Di Leva, G., Garofalo, M. & Croce, C. M. MicroRNAs in cancer. Annu. Rev. Pathol. 9, 287\u2013314, https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104715 (2014).","journal-title":"Annu. Rev. Pathol."},{"key":"59789_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio, A. & Lowe, S. W. The microcosmos of cancer. Nat. 482, 347\u2013355, https:\/\/doi.org\/10.1038\/nature10888 (2012).","journal-title":"Nat."},{"key":"59789_CR17","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ejca.2007.04.002","volume":"43","author":"EA Wiemer","year":"2007","unstructured":"Wiemer, E. A. The role of microRNAs in cancer: no small matter. Eur. J. Cancer 43, 1529\u20131544, https:\/\/doi.org\/10.1016\/j.ejca.2007.04.002 (2007).","journal-title":"Eur. J. Cancer"},{"key":"59789_CR18","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/j.1349-7006.2010.01616.x","volume":"101","author":"G Chai","year":"2010","unstructured":"Chai, G. et al. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci. 101, 1997\u20132004, https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01616.x (2010).","journal-title":"Cancer Sci."},{"key":"59789_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-473","volume":"14","author":"J Masliah-Planchon","year":"2013","unstructured":"Masliah-Planchon, J. et al. MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis. BMC Genomics 14, 473, https:\/\/doi.org\/10.1186\/1471-2164-14-473 (2013).","journal-title":"BMC Genomics"},{"key":"59789_CR20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/bjc.2012.518","volume":"108","author":"N Presneau","year":"2013","unstructured":"Presneau, N. et al. MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. Br. J. Cancer 108, 964\u2013972, https:\/\/doi.org\/10.1038\/bjc.2012.518 (2013).","journal-title":"Br. J. Cancer"},{"key":"59789_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/path.2633","volume":"220","author":"S Subramanian","year":"2010","unstructured":"Subramanian, S. et al. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J. Pathol. 220, 58\u201370, https:\/\/doi.org\/10.1002\/path.2633 (2010).","journal-title":"J. Pathol."},{"key":"59789_CR22","doi-asserted-by":"publisher","first-page":"e0183155","DOI":"10.1371\/journal.pone.0183155","volume":"12","author":"A Amirnasr","year":"2017","unstructured":"Amirnasr, A. et al. Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors. PLoS One 12, e0183155, https:\/\/doi.org\/10.1371\/journal.pone.0183155 (2017).","journal-title":"PLoS One"},{"key":"59789_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/NEN.0b013e3181c55d55","volume":"69","author":"RM Verdijk","year":"2010","unstructured":"Verdijk, R. M. et al. TP53 mutation analysis of malignant peripheral nerve sheath tumors. J. Neuropathol. Exp. Neurol. 69, 16\u201326, https:\/\/doi.org\/10.1097\/NEN.0b013e3181c55d55 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"59789_CR24","unstructured":"WHO Classification of Tumours of the Central Nervous System. Revised 4th edition edn, (International Agency for Research on Cancer, 2016)."},{"key":"59789_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejca.2016.12.018","volume":"75","author":"EAC Wiemer","year":"2017","unstructured":"Wiemer, E. A. C. et al. Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial. Eur. J. Cancer 75, 33\u201340, https:\/\/doi.org\/10.1016\/j.ejca.2016.12.018 (2017).","journal-title":"Eur. J. Cancer"},{"key":"59789_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108, https:\/\/doi.org\/10.1038\/nprot.2008.73 (2008).","journal-title":"Nat. Protoc."},{"key":"59789_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0277-5379(91)90142-z","volume":"27","author":"YP Keepers","year":"1991","unstructured":"Keepers, Y. P. et al. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur. J. Cancer 27, 897\u2013900, https:\/\/doi.org\/10.1016\/0277-5379(91)90142-z (1991).","journal-title":"Eur. J. Cancer"},{"key":"59789_CR28","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","volume":"275","author":"V Korinek","year":"1997","unstructured":"Korinek, V. et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC\u2212\/\u2212 colon carcinoma. Sci. 275, 1784\u20131787, https:\/\/doi.org\/10.1126\/science.275.5307.1784 (1997).","journal-title":"Sci."},{"key":"59789_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-29","volume":"5","author":"E Bandres","year":"2006","unstructured":"Bandres, E. et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5, 29, https:\/\/doi.org\/10.1186\/1476-4598-5-29 (2006).","journal-title":"Mol. Cancer"},{"key":"59789_CR30","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/onc.2008.474","volume":"28","author":"X Chen","year":"2009","unstructured":"Chen, X. et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28, 1385\u20131392, https:\/\/doi.org\/10.1038\/onc.2008.474 (2009).","journal-title":"Oncogene"},{"key":"59789_CR31","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1101\/gad.1950610","volume":"24","author":"OA Kent","year":"2010","unstructured":"Kent, O. A. et al. Repression of the miR-143\/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes. Dev. 24, 2754\u20132759, https:\/\/doi.org\/10.1101\/gad.1950610 (2010).","journal-title":"Genes. Dev."},{"key":"59789_CR32","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1073\/pnas.0808042106","volume":"106","author":"M Sachdeva","year":"2009","unstructured":"Sachdeva, M. et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl Acad. Sci. USA 106, 3207\u20133212, https:\/\/doi.org\/10.1073\/pnas.0808042106 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59789_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0284-1","volume":"8","author":"MI Almeida","year":"2016","unstructured":"Almeida, M. I. & Calin, G. A. The miR-143\/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med. 8, 29, https:\/\/doi.org\/10.1186\/s13073-016-0284-1 (2016).","journal-title":"Genome Med."},{"key":"59789_CR34","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2014.03.055","volume":"157","author":"RR Chivukula","year":"2014","unstructured":"Chivukula, R. R. et al. An essential mesenchymal function for miR-143\/145 in intestinal epithelial regeneration. Cell 157, 1104\u20131116, https:\/\/doi.org\/10.1016\/j.cell.2014.03.055 (2014).","journal-title":"Cell"},{"key":"59789_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2876","volume":"4","author":"CW Lin","year":"2013","unstructured":"Lin, C. W. et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat. Commun. 4, 1877, https:\/\/doi.org\/10.1038\/ncomms2876 (2013).","journal-title":"Nat. Commun."},{"key":"59789_CR36","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/0008-5472.CAN-08-0951","volume":"68","author":"R Nagel","year":"2008","unstructured":"Nagel, R. et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res. 68, 5795\u20135802, https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0951 (2008).","journal-title":"Cancer Res."},{"key":"59789_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/cgt.2008.77","volume":"16","author":"AW Tong","year":"2009","unstructured":"Tong, A. W. et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther. 16, 206\u2013216, https:\/\/doi.org\/10.1038\/cgt.2008.77 (2009).","journal-title":"Cancer Gene Ther."},{"key":"59789_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau, J., Menezes, M. R., Cao, S. & Hagan, J. P. The LIN28\/let-7 Pathway in Cancer. Front. Genet. 8, 31, https:\/\/doi.org\/10.3389\/fgene.2017.00031 (2017).","journal-title":"Front. Genet."},{"key":"59789_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1158\/1078-0432.CCR-13-0780","volume":"20","author":"A Luscan","year":"2014","unstructured":"Luscan, A. et al. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis. Clin. Cancer Res. 20, 358\u2013371, https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0780 (2014).","journal-title":"Clin. Cancer Res."},{"key":"59789_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1158\/2159-8290.CD-13-0081","volume":"3","author":"AL Watson","year":"2013","unstructured":"Watson, A. L. et al. Canonical Wnt\/beta-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. Cancer Discov. 3, 674\u2013689, https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0081 (2013).","journal-title":"Cancer Discov."},{"key":"59789_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","volume":"65","author":"T Tucker","year":"2005","unstructured":"Tucker, T., Wolkenstein, P., Revuz, J., Zeller, J. & Friedman, J. M. Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurol. 65, 205\u2013211, https:\/\/doi.org\/10.1212\/01.wnl.0000168830.79997.13 (2005).","journal-title":"Neurol."},{"key":"59789_CR42","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/gcc.20921","volume":"50","author":"E Beert","year":"2011","unstructured":"Beert, E. et al. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes. Chromosomes Cancer 50, 1021\u20131032, https:\/\/doi.org\/10.1002\/gcc.20921 (2011).","journal-title":"Genes. Chromosomes Cancer"},{"key":"59789_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/gcc.2870100405","volume":"10","author":"E Legius","year":"1994","unstructured":"Legius, E. et al. TP53 mutations are frequent in malignant NF1 tumors. Genes. Chromosomes Cancer 10, 250\u2013255, https:\/\/doi.org\/10.1002\/gcc.2870100405 (1994).","journal-title":"Genes. Chromosomes Cancer"},{"key":"59789_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature13561","volume":"514","author":"T De Raedt","year":"2014","unstructured":"De Raedt, T. et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nat. 514, 247\u2013251, https:\/\/doi.org\/10.1038\/nature13561 (2014).","journal-title":"Nat."},{"key":"59789_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee, W. et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat. Genet. 46, 1227\u20131232, https:\/\/doi.org\/10.1038\/ng.3095 (2014).","journal-title":"Nat. Genet."},{"key":"59789_CR46","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ng.3116","volume":"46","author":"M Zhang","year":"2014","unstructured":"Zhang, M. et al. Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat. Genet. 46, 1170\u20131172, https:\/\/doi.org\/10.1038\/ng.3116 (2014).","journal-title":"Nat. Genet."},{"key":"59789_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","volume":"120","author":"SM Johnson","year":"2005","unstructured":"Johnson, S. M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635\u2013647, https:\/\/doi.org\/10.1016\/j.cell.2005.01.014 (2005).","journal-title":"Cell"},{"key":"59789_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","volume":"26","author":"TC Chang","year":"2007","unstructured":"Chang, T. C. et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745\u2013752, https:\/\/doi.org\/10.1016\/j.molcel.2007.05.010 (2007).","journal-title":"Mol. Cell"},{"key":"59789_CR49","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1750-3639.2004.tb00062.x","volume":"14","author":"N Holtkamp","year":"2004","unstructured":"Holtkamp, N. et al. Subclassification of nerve sheath tumors by gene expression profiling. Brain Pathol. 14, 258\u2013264, https:\/\/doi.org\/10.1111\/j.1750-3639.2004.tb00062.x (2004).","journal-title":"Brain Pathol."},{"key":"59789_CR50","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tcb.2010.03.001","volume":"20","author":"M Nishita","year":"2010","unstructured":"Nishita, M., Enomoto, M., Yamagata, K. & Minami, Y. Cell\/tissue-tropic functions of Wnt5a signaling in normal and cancer cells. Trends Cell Biol. 20, 346\u2013354, https:\/\/doi.org\/10.1016\/j.tcb.2010.03.001 (2010).","journal-title":"Trends Cell Biol."},{"key":"59789_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nrg3603","volume":"14","author":"YB Schwartz","year":"2013","unstructured":"Schwartz, Y. B. & Pirrotta, V. A new world of Polycombs: unexpected partnerships and emerging functions. Nat. Rev. Genet. 14, 853\u2013864, https:\/\/doi.org\/10.1038\/nrg3603 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"59789_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00401-016-1540-6","volume":"131","author":"M Rohrich","year":"2016","unstructured":"Rohrich, M. et al. Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol. 131, 877\u2013887, https:\/\/doi.org\/10.1007\/s00401-016-1540-6 (2016).","journal-title":"Acta Neuropathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59789-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:04:55Z","timestamp":1670310295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59789-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59789-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2927"}}